Colombia Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Colombia Pharmaceuticals and Healthcare Report

Colombia Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Colombia Pharmaceuticals and Healthcare Report
Published Oct 22, 2016
91 pages — Published Oct 22, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

In June ----, Astellas established Astellas Farma Colombia, a new affiliate with operations headquartered in Bogota. Colombia joins Astellas Farma Brasil as the company s second affiliate in Latin America. Sandra Cifuentes has been appointed general manager of the affiliate. In May ----, a group of -- House Democrats in the US sent a letter to US Trade Representative (USTR) Michael Froman asking that the Obama administration clarifies its position on compulsory licensing for generic medicines in Colombia. In April ----, Colombia s Health Minister Alejandro Gaviria had announced that the government will issue a Declaration of Public Interest, which will provide a legal pathway for a compulsory licence for Novartis oncology drug Gleevec (imatinib) in Colombia. ...In May ----, a group of -- House Democrats in the US sent a letter to US Trade Representative (USTR) Michael Froman asking that the Obama administration clarifies its position on compulsory licensing for generic medicines in Colombia. In April ----, Colombia s Health Minister Alejandro Gaviria had announced that the government will issue a Declaration of Public Interest, which will provide a legal pathway for a compulsory licence for Novartis oncology drug Gleevec (imatinib) in Colombia.

...Counterfeit drugs continue to represent up to -- of the total marketplace and to undermine research-based and true generic sales. The regulatory system remains challenging, often opaque and overly bureaucratic. ...Large numbers of internally displaced people make healthcare provision and services more difficult to organise. Collection of social security contributions remains a serious problem, with the health insurance system recently declared on a brink of collapse. Most of the local production is dependent on imported active pharmaceutical ingredients (APIs). ...Collection of social security contributions remains a serious problem, with the health insurance system recently declared on a brink of collapse. Most of the local production is dependent on imported active pharmaceutical ingredients (APIs).

...The high cost of modernisation to the local industry will drive continued political resistance to regulatory reform and enforcement. Government attempts to improve access to essential medicines by undermining patent standards could limit attraction to innovative drugmakers. ...

  
Source:
Document ID
1748-183X
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Colombia Pharmaceuticals and Healthcare Report" Oct 22, 2016. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Colombia-Pharmaceuticals-and-Healthcare-Report-2026-406>
  
APA:
Business Monitor International - Industry Reports. (2016). Colombia Pharmaceuticals and Healthcare Report Oct 22, 2016. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Colombia-Pharmaceuticals-and-Healthcare-Report-2026-406>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.